The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of surufatinib (S) plus KN046 (K) and chemotherapy in first line (1L) advanced pancreatic cancer (PC): A single-arm, phase 1b/2 trial.
 
Wen-Quan Wang
No Relationships to Disclose
 
Lin-Hui Tang
No Relationships to Disclose
 
Yu Li
No Relationships to Disclose
 
Fei Liang
No Relationships to Disclose
 
Yao-Lin Xu
No Relationships to Disclose
 
Yue-Ming Zhang
No Relationships to Disclose
 
Wei Gan
No Relationships to Disclose
 
Ning Pu
No Relationships to Disclose
 
Hua-Xiang Xu
No Relationships to Disclose
 
Jun-Yi He
No Relationships to Disclose
 
Lei Zhang
No Relationships to Disclose
 
Chen-Ye Shi
No Relationships to Disclose
 
Wen-Chuan Wu
No Relationships to Disclose
 
Wen-Hui Lou
No Relationships to Disclose
 
Liang Liu
No Relationships to Disclose